PILL targets three times the daily move of a pharmaceutical and medical index. It sits between CURE and LABU in character — narrower than broad healthcare, but weighted toward established drug makers rather than the clinical-stage names that dominate biotech.
Direxion Daily Pharmaceutical & Medical Bull 3X ETF (PILL) is currently trading at $22.62. Over the past 52 weeks, PILL has traded between a low of $7.06 and a high of $24.15. Recent daily volume is around 40.9K. These figures update live as the market moves.
Swap exposure to a pharmaceuticals and medical index, reset daily. It is a smaller and less liquid fund than CURE or LABU, which shows up as wider spreads — a real cost on a 3x instrument, where the spread is paid on leveraged exposure.
Patent cliffs and pipeline news above all: a blockbuster drug losing exclusivity can remove billions in revenue on a known date, and the market prices that in advance. Beyond that, drug pricing legislation, FDA approvals, and litigation outcomes. Large pharma is also a serial acquirer, so deal announcements move both buyer and sector.
FDA decision dates for major drugs, quarterly results from the large pharmaceutical companies, and drug-pricing policy news. Check the spread before trading it — PILL's lower volume makes execution cost a bigger factor than it is on the larger leveraged funds.